Early Thanksgiving Present: Obama Signs Compounding/Track And Trace Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
The Drug Quality and Security Act moves to implementation phase after Nov. 27 signing.
You may also be interested in...
FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary
Commissioner Hamburg asks for more power over non-traditional compounding to better regulate companies like the New England Compounding Center, but several House members say it looks like the agency already has the authority it needs.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.
Rare Cancer Development Consortium Moving Toward Target Selection
An upcoming public meeting will include a look at platforms before the first targets are chosen.